Cascadian Therapeutics Prices $82.5 Million Concurrent Offerings Of Common Stock And Preferred Stock

Cascadian Therapeutics, Inc., today announced the pricing of the previously announced concurrent but separate underwritten offerings of 23,182,000 shares of its common stock at a price to the public of $3.30 per share.